14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
On June 26, 2019, the Toledo City Council approved Ordinance 173-19, titled “Pay Equity Act to Proh...
Read More >
The U.S. Court of Appeals for the Tenth Circuit recently ruled that the Fair Labor Standards Act (“...
Read More >
In order to support the District of Columbia’s new Universal Paid Leave Act (the Act), covered empl...
Read More >
The UK government has tabled changes to the Enterprise Act 2002 to expand the circumstances in which...
Read More >
As we previously reported, on December 20, President Trump signed into law the “Setting Every Commu...
Read More >
In CLC Roofing v. Helzer, a roofer purchased shingles from a seller and stored them on the seller’s...
Read More >